Home / Drugs / Alglucosidase alfa

Alglucosidase alfa

FDA Drug Profile

Drug Details

Generic Name
Alglucosidase alfa
Brand Names
N/A
Application Number
Sponsor
Genzyme Corporation
NDC Codes
1
Dosage Forms
SOLUTION
Routes
N/A
Active Ingredients
ALGLUCOSIDASE ALFA

Indications and Usage

1 INDICATIONS AND USAGE NEXVIAZYME is indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). NEXVIAZYME is a hydrolytic lysosomal glycogen-specific enzyme indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). ( 1 )